These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 12489604)
21. A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs. Finlinson HA; Oliver-Vélez D; Deren S; Cant JG; Colón HM; Robles RR; Kang SY; Andía JF Subst Use Misuse; 2006; 41(9):1313-36. PubMed ID: 16861181 [TBL] [Abstract][Full Text] [Related]
22. Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island. Zaller ND; Yokell MA; Nayak SM; Fu JJ; Bazazi AR; Rich JD J Urban Health; 2012 Aug; 89(4):659-70. PubMed ID: 22427232 [TBL] [Abstract][Full Text] [Related]
23. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R; Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634 [TBL] [Abstract][Full Text] [Related]
24. Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States metropolitan areas. Gleghorn AA; Wright-De Agüero L; Flynn C J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S30-6. PubMed ID: 9663621 [TBL] [Abstract][Full Text] [Related]
25. Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015. Stopka TJ; Donahue A; Hutcheson M; Green TC J Am Pharm Assoc (2003); 2017; 57(2S):S34-S44. PubMed ID: 28189540 [TBL] [Abstract][Full Text] [Related]
26. Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia. Vorobjov S; Uusküla A; Abel-Ollo K; Talu A; Jarlais DD J Urban Health; 2009 Nov; 86(6):918-28. PubMed ID: 19921542 [TBL] [Abstract][Full Text] [Related]
27. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation. Linas BP; Coffin PO; Backes G; Vlahov D J Urban Health; 2000 Dec; 77(4):768-80. PubMed ID: 11194316 [TBL] [Abstract][Full Text] [Related]
28. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. Coffin PO; Ahern J; Dorris S; Stevenson L; Fuller C; Vlahov D J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S62-7. PubMed ID: 12489618 [TBL] [Abstract][Full Text] [Related]
29. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. Cotten-Oldenburg NU; Carr P; DeBoer JM; Collison EK; Novotny G J Acquir Immune Defic Syndr; 2001 Jun; 27(2):183-92. PubMed ID: 11404541 [TBL] [Abstract][Full Text] [Related]
30. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993. Valleroy LA; Weinstein B; Jones TS; Groseclose SL; Rolfs RT; Kassler WJ J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):73-81. PubMed ID: 7648288 [TBL] [Abstract][Full Text] [Related]
31. Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study. Fedorova EV; Skochilov RV; Heimer R; Case P; Beletsky L; Grau LE; Kozlov AP; Shaboltas AV BMC Public Health; 2013 Mar; 13():183. PubMed ID: 23452390 [TBL] [Abstract][Full Text] [Related]
32. Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales. Costenbader EC; Zule WA; Coomes CC Int J Drug Policy; 2010 Sep; 21(5):425-8. PubMed ID: 20097052 [TBL] [Abstract][Full Text] [Related]
33. Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia. Taussig J; Junge B; Burris S; Jones TS; Sterk CE J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S40-5. PubMed ID: 12489614 [TBL] [Abstract][Full Text] [Related]
34. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468 [TBL] [Abstract][Full Text] [Related]
35. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Fuller CM; Ahern J; Vadnai L; Coffin PO; Galea S; Factor SH; Vlahov D J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S77-82. PubMed ID: 12489621 [TBL] [Abstract][Full Text] [Related]
36. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users. Lurie P; Gorsky R; Jones TS; Shomphe L J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635 [TBL] [Abstract][Full Text] [Related]
37. Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention. Zaller ND; Yokell MA; Apeakorang N; Gaggin J; Case P J Health Care Poor Underserved; 2012 Aug; 23(3):1310-26. PubMed ID: 24212176 [TBL] [Abstract][Full Text] [Related]
38. Syringe exchange programs: Impact on injection drug users and the role of the pharmacist from a U.S. perspective. Nacopoulos AG; Lewtas AJ; Ousterhout MM J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):148-57. PubMed ID: 20199955 [TBL] [Abstract][Full Text] [Related]
39. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI. Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724 [TBL] [Abstract][Full Text] [Related]
40. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018. Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]